Peripheral T-Cell Lymphoma with Aberrant Expression of CD79a and CD20: A Diagnostic Pitfall
- 1 February 2001
- journal article
- case report
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (2) , 105-110
- https://doi.org/10.1038/modpathol.3880265
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's diseaseHistopathology, 2007
- Immunoreactivity of B-Cell Markers (CD79a, L26) in Rare Cases of Extranodal Cytotoxic Peripheral T- (NK/T-) Cell LymphomasLaboratory Investigation, 2000
- Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.The Journal of Experimental Medicine, 1996
- Immunodeficiency-Associated Malignant LymphomaThe American Journal of Surgical Pathology, 1994
- S-lOO-Positive T-Cell Lymphoproliferative Disorder:A Case Report and Review of the LiteratureAmerican Journal of Clinical Pathology, 1994
- CD20+ T-Cell Lymphoma:Neoplastic Transformation of a Normal T-Cell SubsetAmerican Journal of Clinical Pathology, 1994
- Epstein-Barr Virus Is Infrequently Identified in Non-Hodgkinʼs Lymphomas Associated with Hodgkinʼs DiseaseThe American Journal of Surgical Pathology, 1994
- S-100-positive T cells are largely restricted to a CD8-positive, 9.3-negative subsetVirchows Archiv B Cell Pathology Including Molecular Pathology, 1987
- S-100 antigen in human T lymphocytesBiochemical and Biophysical Research Communications, 1982
- Immunoblastic LymphadenopathyNew England Journal of Medicine, 1975